Skip to content

PolitiKit

Paul Mahon's lobbying: the registrations they file and every meeting they've reported since November 2021.

← Lobbying

Registrant (responsible officer)

Paul Mahon

President and Chief Executive Officer

For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.

Meetings this Parliament
0
Since Nov 2021
86
Active registrations
0

Reported meetings

    • Roy Karam · Director of Operations, Health Canada (HC)
    • Stephanie Claxton · Special Assistant, Health Canada (HC)
    Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more

    Seeking to raise awareness about prescription drug coverage policy considerations and concerns in context of national universal pharmacare proposals directly and as a participant in the Together for Better Health Coalition. Other related initiatives include high cost drugs for rare disease and PMPRB regulations

    Official report

    • Daniel MacDonald · Director General, Health Canada (HC)
    • Margaret Sharp · Director, Health Canada (HC)
    Seeking to raise awareness about prescription drug coverage policy considerations and concerns in context of national universal pharmacare proposals directly and as a participant in the Together for Better Health Coalition. Other related initiatives include high cost drugs for rare disease and PMPRB regulations Read more

    Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services

    Official report

    • Manuel Dussault · Senior Director, Finance Canada (FIN)
    Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology

    Official report

  • Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more

    Official report

    • Jill Pilgrim · Director of Policy, Health Care Systems and Legal Affairs, Health Canada (HC)
    • Cyndi Jenkins · Chief of Staff to the Minister, Health Canada (HC)
    • Jocelyne Voisin · Assistant Deputy Minister, Health Canada (HC)
    • Jennifer Goodyer · Executive Director, Health Canada (HC)
    Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more

    Official report

    • Manuel Dussault · Senior Director, Finance Canada (FIN)
    • Steven Begg · Senior Policy Officer, Finance Canada (FIN)
    • Yannick Cote-Steben · Analyst-Economist, Finance Canada (FIN)
    Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology

    Official report

    • Jonathan Reid · Analyst, Finance Canada (FIN)
    • Kirsten Fraser · Director, Finance Canada (FIN)
    Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology

    Official report

    • Michelle Boudreau · Executive Director, Office of Pharmaceutical Management Strategies, Health Canada (HC)
    • Daniel MacDonald · Director General, Health Canada (HC)
    • Clara Wilson · Senior Policy Advisor, Health Canada (HC)
    Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more

    Official report

    • Greg Orencsak · Deputy Minister, Health Canada (HC)
    • Michelle Boudreau · Assistant Deputy Minister, Health Canada (HC)
    • Krista Urchenko · Senior Advisor, Health Canada (HC)
    • Marci Gillespie · Assistant Director of Policy, Health Canada (HC)
    Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Read more

    Official report

    • Aaron Wudrick · Director of Policy, House of Commons
    Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals

    Official report

    • Chris Forbes · Deputy Minister of Finance, Finance Canada (FIN)
    • Greg Orencsak · Deputy Minister, Health Canada (HC)
    Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals Read more

    Taxation - discussion of taxation policy for financial institutions.

    Official report

  • Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals

    Official report

    • Stephen Ellis · Member of Parliament, House of Commons
    Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals

    Official report

    • Bryce McRae · Manager of Stakeholder Relations, House of Commons
    Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals

    Official report

  • Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals

    Official report

    • Jill Pilgrim · Director of Policy, Health Care Systems and Legal Affairs, Health Canada (HC)
    • Jade Mallette · Director of Parliamentary Affairs, Health Canada (HC)
    Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals

    Official report

    • Anne Loosen · Senior Project Leader, Finance Canada (FIN)
    • Mark Radley · Economist, Finance Canada (FIN)
    Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology

    Official report

    • Kirsten Fraser · Director, Finance Canada (FIN)
    Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology

    Official report

    • Manuel Dussault · Senior Director, Finance Canada (FIN)
    Federal Financial Services legislation review, with respect to Financial Institutions policies, infrastructure, open banking, and financial technology

    Official report

  • Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals

    Official report

    • Mark Radley · Economist, Privy Council Office (PCO)
    • Tanjana Islam · Analyst, Finance Canada (FIN)

    Financial Institutions

    Official report

    • Khusro Saeedi · Director, Finance Canada (FIN)
    • Connor Colvin · Economist, Finance Canada (FIN)

    Financial Institutions

    Official report

    • Christophe Cinqmars-Viau · Senior Policy Advisor, Finance Canada (FIN)

    Financial Institutions

    Official report

  • Financial InstitutionsPrivacy and Access to Information

    Official report

    • Mark Schaan · Senior Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Francis Bilodeau · Associate Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Andrea Johnston · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Brian Masse · Member of Parliament, House of Commons
    and 7 more
    • Sami Khoury · Head, Communications Security Establishment Canada (CSEC)
    • Colin Deacon · Senator, Senate of Canada
    • David Dlab · Director of Parliamentary Affairs, Senate of Canada
    • Laurel Chester · Director of Parliamentary Affairs, Intergovernmental Affairs Secretariat (IGA)
    • Jaxson Khan · Sr Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    • Jennifer O'Connell · Member of Parliament, House of Commons
    • Etienne-Rene Massie · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)

    Economic DevelopmentFinancial InstitutionsInfrastructure

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.